OSE Immunotherapeutics SA (EPA:OSE)
3.680
-0.126 (-3.31%)
At close: Mar 13, 2026
OSE Immunotherapeutics Market Cap
OSE Immunotherapeutics has a market cap or net worth of €82.51 million as of March 13, 2026. Its market cap has decreased by -40.31% in one year.
Market Cap
82.51M
Enterprise Value
90.36M
Revenue
1.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.68
Market Cap Chart
Since March 30, 2015, OSE Immunotherapeutics's market cap has decreased from 104.30M to 82.51M, a decrease of -20.89%. That is a compound annual growth rate of -2.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 82.51M | -28.54% |
| Dec 31, 2025 | 115.47M | -26.37% |
| Dec 31, 2024 | 156.83M | 94.71% |
| Dec 29, 2023 | 80.55M | -34.73% |
| Dec 30, 2022 | 123.40M | -34.26% |
| Dec 31, 2021 | 187.71M | 45.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 227.82M |
| Transgene | 213.59M |
| Sensorion | 198.23M |
| MaaT Pharma | 129.46M |
| Innate Pharma | 117.16M |
| Adocia | 116.19M |
| ABIONYX Pharma | 115.18M |
| Valerio Therapeutics Société anonyme | 65.99M |